According to experts, soon the integration of artificial intelligence (AI) into healthcare will drastically shift from a novelty, to a critical resource. With over 800 FDA-cleared health AI ...

The FDA cleared the investigational new drug application for REC-4539, allowing for the start of a phase 1/2 trial in small ...

Recursion announced that the UK Medicines and Healthcare Products Regulatory Agency has cleared a clinical trial application for a Phase 1 ...

Many new Android apps are out there. Keeping track of them is tough, but we’re happy to do that hard work for you. We’ve scoured the internet to find the best new Android apps and new Android ...

Jobless claim applications ticked down by 1,000 to 219,000 for the week of Dec. 21, the Labor Department reported Thursday. That’s fewer than the 223,000 analysts forecast. Continuing claims, the ...

Recursion is using artificial intelligence and machine learning to accelerate drug research and development. The company benefits from partnerships with major tech and healthcare leaders ...

Salt Lake City, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize ...

Jobless claim applications declined by 22,000 to 220,000 for the week of Dec. 14, the Labor Department reported Thursday. That’s fewer than the 229,000 analysts were forecasting. Continuing claims, ...

Recursive partitioning analysis (RPA) was used to develop a novel prognostic system. Results: The 1-, 3-, and 5-year ROC curves, used to predict cancer-specific survival (CSS) and overall survival (OS ...

Recursion is poised to be a leader in the technological revolution of pharmaceutical companies, providing a real-world application to AI-powered tools, reducing the time and budget required for ...